Central Line Associated Blood-Stream Infection (CLA-BSI) rate
[[IndicatorDescription:: CLA-BSI defined using CDC case definition.]]
| Indicators | |
| Indicator: | Central Line Associated Blood-Stream Infection (CLA-BSI) rate |
| Created/Raw: | Created |
| Program: | Critical Care |
| Start Date: | |
| End Date: | |
| Reports: | Directors Quarterly and Annual Report (Critical Care), STB ICUs VAP Rate, CLIBSI Rate Summary, WRHA ICU Hospital-Acquired Conditions |
| Data Dependencies(Reports/Indicators/Data Elements): | |
QI domain
- Safe
Significance
CLA-BSIs increase morbidity, mortality and costs. It can be prevented using evidence-based interventions. This measure can be used to detect changes related to implementation or lack of adherence to these best practices.
Sampling Plan / Procedure
|
What are the details? |
Includion Criteria
|
|
What are the details? |
Exclusion Criteria
|
|
What are the details? |
Frequency
|
|
What are the details? |
Definition and Derivation
CLA-BSI per 1000 Central line days.
Numerator
|
|
What are the details? |
Denominator
|
|
What are the details? |
Data Sources
|
|
What are the details? |
SAS Program
|
|
What are the details? |
Report Users
|
|
What are the details? |
Related articles
| Related articles: |